Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 10;84(6):575-9.
doi: 10.1212/WNL.0000000000001225.

Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels

Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels

Jennifer Spillane et al. Neurology. .

Abstract

Objective: To determine whether immunoglobulin G (IgG) from patients with Lambert-Eaton myasthenic syndrome (LEMS) decreases action potential–evoked synaptic vesicle exocytosis,and whether the effect is mediated by P/Q-type voltage-gated calcium channels (VGCCs).

Methods: IgG was obtained from 4 patients with LEMS (3 males, 1 female), including 2 patients with lung malignancy. Antibodies against P/Q-type VGCCs were detected in all 4 patients, and against N-type VGCCs in 2. We incubated neuronal cultures with LEMS IgG and determined the size of the total recycling pool of synaptic vesicles and the rate of action potential–evoked exocytosis using fluorescence imaging of the amphiphilic dye SynaptoRed C1. Pooled IgG from healthy volunteers was used as a control. We repeated the experiments on synapses lacking P/Q-type calcium channels from a Cacna1a knockout mouse to determine whether these channels account for the pathogenic effect of LEMS IgG.

Results: LEMS IgG had no effect on the total recycling pool size but significantly reduced the rate of action potential–evoked synaptic exocytosis in wild-type neurons when compared with neurons treated with control IgG. In contrast, LEMS IgG had no effect on the rate of synaptic vesicle exocytosis in neurons lacking P/Q-type channels.

Conclusions: These data provide direct evidence that LEMS IgG inhibits neurotransmitter release by acting on P/Q-type VGCCs.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Fluorescence measurements of evoked vesicular release in rat cultures after incubation in control or LEMS IgG
(A) Experimental protocol showing the sequence of SRC1 incubation, stimulation to load boutons, to evoke exocytosis, and to achieve complete destaining, and fluorescence imaging. (B, C) Representative SRC1 imaging experiments in cultures treated with control (B) or with LEMS IgG (C). Fluorescence microscopy images (top) show gradual decrease of fluorescence at successive time points as indicated during the experiment. Fluorescence time courses in 2 pairs of representative boutons (arrows) are shown below in relative fluorescence units (RFU). Spontaneous and evoked destaining rates were fitted with mono-exponential curves. The specific action potential–dependent rate of destaining kAP was calculated as kAP = kEVkSP. Scale bars: 5 μm. AP = action potential; IgG = immunoglobulin G; LEMS = Lambert-Eaton myasthenic syndrome; SRC1 = SynaptoRed C1.
Figure 2
Figure 2. LEMS IgG reduces evoked exocytosis but not the total recycling pool size
Effects of LEMS and control IgG on kAP (A) and relative TRP size (B). Left panels show cumulative distributions of mean kAP and TRP size values obtained in individual experiments (average of 10–50 boutons in each experiment). Data derived with samples obtained from each of 4 patients with LEMS are shown as thin colored lines. LEMS samples 1–4 are color-coded as in the legend, and were used in 3, 9, 8, and 6 experiments, respectively. Thick red line, pooled LEMS IgG data; thick black line, control IgG data. Right panels show the mean (±SEM) values for the pooled data (LEMS IgG n = 26 experiments, control IgG n = 21 experiments, *p < 0.05). IgG = immunoglobulin G; LEMS = Lambert-Eaton myasthenic syndrome; ns = nonsignificant; RFU = relative fluorescence units; TRP = total recycling pool.
Figure 3
Figure 3. P/Q-type channels are required for inhibition of vesicular release by LEMS IgG
Effects of LEMS and control IgG on kAP (A) and relative TRP size (B) in WT and Cacna1a+/− (KO) neurons. Left panels show cumulative distributions of mean kAP and TRP size values obtained in individual experiments. Right panels show the mean (±SEM) values for the pooled data. Data are from 602 boutons in 15 experiments (WT, control, black line), 138 boutons in 5 experiments (WT, LEMS, gray), 303 boutons in 15 experiments (KO, control, red), and 175 boutons in 6 experiments (KO, LEMS, pink). **p < 0.01. IgG = immunoglobulin G; KO = knockout; LEMS = Lambert-Eaton myasthenic syndrome; ns = nonsignificant; RFU = relative fluorescence units; TRP = total recycling pool; WT = wild-type.

References

    1. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467–1474. 10.1056/NEJM199506013322203. - DOI - PubMed
    1. Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997;147:35–42. - PubMed
    1. Protti DA, Uchitel OD. Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin omega-Aga-IVA. Neuroreport 1993;5:333–336. - PubMed
    1. Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 2011;10:1098–1107. 10.1016/S1474-4422(11)70245-9. - DOI - PubMed
    1. Lang B, Newsom-Davis J, Wray D, Vincent A, Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981;2:224–226. - PubMed

Publication types

MeSH terms